The Floor · H.Res. 1285 · Committee
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
No sponsor archived.
No committee referrals archived.
Path through Congress · started in the House
H.Res. 1285 · 119th
Status
Committee
Introduced
Missing date
Committee
Missing date
House floor
Senate floor
Resolving differences
Enrolled
President's desk
Became law
Latest action · May 14, 2026
Referred to the House Committee on Energy and Commerce.
No recorded roll calls are listed for this bill. Many measures pass by voice vote or unanimous consent without a member-by-member tally. If Congress.gov later shows recorded votes, they will appear here.
Archive built 2026-09-25 from Library of Congress Congress.gov API.